
Itamar Medical Ltd. Long-Term Debt 2011-2026 | ITMR
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt Itamar Medical Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 154 K | - | - | - | 8.17 M | 14.9 M | 14.6 M | 12.7 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.9 M | 154 K | 10.1 M |
Long-Term Debt of other stocks in the Medical devices industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
1.72 B | $ 13.17 | 0.46 % | $ 1.78 B | ||
|
BIOLASE
BIOL
|
11.8 M | - | -13.19 % | $ 166 K | ||
|
GenMark Diagnostics, Inc.
GNMK
|
71.3 M | - | - | $ 1.77 B | ||
|
Allied Healthcare Products
AHPI
|
2.93 K | - | 3.58 % | $ 2.21 M | ||
|
Eargo
EAR
|
11.9 M | - | - | $ 10.2 M | ||
|
Delcath Systems
DCTH
|
835 K | $ 10.8 | 4.05 % | $ 387 M | ||
|
Apollo Endosurgery
APEN
|
34 M | - | - | $ 475 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
430 K | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
17.1 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
1.1 M | $ 25.6 | -0.43 % | $ 216 M | ||
|
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
7.56 M | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
2.16 M | $ 3.47 | 4.52 % | $ 130 M | ||
|
Aziyo Biologics
AZYO
|
3.59 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Helius Medical Technologies
HSDT
|
12 K | $ 2.12 | 3.92 % | $ 1.29 M | ||
|
Inspire Medical Systems
INSP
|
30 M | $ 56.7 | 1.0 % | $ 1.67 B | ||
|
Conformis
CFMS
|
20.6 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
345 M | $ 61.0 | 1.5 % | $ 3.33 B | ||
|
ClearPoint Neuro
CLPT
|
49.1 M | $ 11.37 | 1.7 % | $ 322 M | ||
|
Cardiovascular Systems
CSII
|
1.33 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
16.7 M | $ 0.61 | 0.36 % | $ 38 M | ||
|
CryoLife, Inc.
CRY
|
290 M | - | -4.14 % | $ 702 M | ||
|
Invacare Corporation
IVC
|
354 M | - | - | $ 24.7 M | ||
|
IRIDEX Corporation
IRIX
|
98 K | $ 1.03 | - | $ 17.4 M | ||
|
Dynatronics Corporation
DYNT
|
1.11 M | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
38.6 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
7.64 M | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
99.8 M | $ 15.65 | 3.92 % | $ 367 M | ||
|
Butterfly Network
BFLY
|
20.4 M | $ 5.4 | 12.97 % | $ 1.14 B | ||
|
Intersect ENT, Inc.
XENT
|
63.6 M | - | - | $ 955 M | ||
|
GBS
GBS
|
1.65 M | - | -0.57 % | $ 7.12 M | ||
|
Sintx Technologies
SINT
|
2.84 M | $ 2.41 | 14.22 % | $ 6.68 M | ||
|
Globus Medical
GMED
|
436 K | $ 91.34 | 1.29 % | $ 12.4 B | ||
|
TransMedics Group
TMDX
|
453 M | $ 100.01 | -0.77 % | $ 3.4 B | ||
|
NanoVibronix
NAOV
|
28 K | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
834 M | $ 36.8 | 0.38 % | $ 1.14 B | ||
|
Integer Holdings Corporation
ITGR
|
1.19 B | $ 84.03 | -5.06 % | $ 2.92 B | ||
|
Stryker Corporation
SYK
|
14.9 B | $ 294.73 | -6.47 % | $ 113 B | ||
|
Edwards Lifesciences Corporation
EW
|
598 M | $ 83.98 | 0.57 % | $ 49.1 B | ||
|
Tandem Diabetes Care
TNDM
|
310 M | $ 19.41 | -0.61 % | $ 1.32 B | ||
|
LENSAR
LNSR
|
1.99 M | $ 5.61 | 7.27 % | $ 67.1 M | ||
|
Pulmonx Corporation
LUNG
|
37 M | $ 1.35 | 5.47 % | $ 54.9 M | ||
|
MiMedx Group
MDXG
|
16.5 M | $ 3.68 | 9.52 % | $ 544 M | ||
|
Myomo
MYO
|
11.2 M | $ 0.9 | 4.16 % | $ 37.7 M |